Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)

  1. Drake, M.J.
  2. MacDiarmid, S.
  3. Chapple, C.R.
  4. Esen, A.
  5. Athanasiou, S.
  6. Cambronero Santos, J.
  7. Mitcheson, D.
  8. Herschorn, S.
  9. Siddiqui, E.
  10. Huang, M.
  11. Stoelzel, M.
Revista:
International Journal of Clinical Practice

ISSN: 1742-1241,  1368-5031

Ano de publicación: 2017

Volume: 71

Número: 5

Tipo: Artigo

DOI: 10.1111/IJCP.12944 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus